Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Ahrens

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Stem Cells Translational Medicine|June 5, 2015
First-in-Human Case Study: Multipotent Adult Progenitor Cells for Immunomodulation After Liver TransplantationYorick Soeder, Martin Loss, Christian L Johnson, et al.
Transfusion|April 5, 2014
Clinical management of patients receiving cell-based immunoregulatory therapyJames A Hutchinson, Norbert Ahrens, Paloma Riquelme, et al.
Transplantation|June 9, 2017
DHRS9 Is a Stable Marker of Human Regulatory MacrophagesPaloma Riquelme, Giada Amodio, Camila Macedo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 25, 2014
Laser ablation-inductively coupled plasma mass spectrometry: an emerging technology for detecting rare cells in tissue sectionsAmy J Managh, Robert W Hutchinson, Paloma Riquelme, et al.
Nature Communications|July 22, 2018
TIGIT<sup>+</sup> iTregs elicited by human regulatory macrophages control T cell immunityPaloma Riquelme, Jan Haarer, Anja Kammler, et al.
Frontiers in Immunology|May 1, 2015
Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) - From Preclinical Studies to a Clinical Phase II TrialHanno M Specht, Norbert Ahrens, Christiane Blankenstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2020
Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical TrialGabriele Multhoff, Sophie Seier, Stefan Stangl, et al.
Lancet (London, England)|May 25, 2020
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trialsBirgit Sawitzki, Paul N Harden, Petra Reinke, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Stem Cells Translational Medicine|June 5, 2015
First-in-Human Case Study: Multipotent Adult Progenitor Cells for Immunomodulation After Liver TransplantationYorick Soeder, Martin Loss, Christian L Johnson, et al.
Transfusion|April 5, 2014
Clinical management of patients receiving cell-based immunoregulatory therapyJames A Hutchinson, Norbert Ahrens, Paloma Riquelme, et al.
Transplantation|June 9, 2017
DHRS9 Is a Stable Marker of Human Regulatory MacrophagesPaloma Riquelme, Giada Amodio, Camila Macedo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 25, 2014
Laser ablation-inductively coupled plasma mass spectrometry: an emerging technology for detecting rare cells in tissue sectionsAmy J Managh, Robert W Hutchinson, Paloma Riquelme, et al.
Nature Communications|July 22, 2018
TIGIT<sup>+</sup> iTregs elicited by human regulatory macrophages control T cell immunityPaloma Riquelme, Jan Haarer, Anja Kammler, et al.
Frontiers in Immunology|May 1, 2015
Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) - From Preclinical Studies to a Clinical Phase II TrialHanno M Specht, Norbert Ahrens, Christiane Blankenstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2020
Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical TrialGabriele Multhoff, Sophie Seier, Stefan Stangl, et al.
Lancet (London, England)|May 25, 2020
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trialsBirgit Sawitzki, Paul N Harden, Petra Reinke, et al.
Pageof 5